| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BTMDbiote Corp. | 73.33M | 2.39 | 25.95 | 6.38% | 14.72% | 52.93% |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 109.98M | 116.57M | 139.4M | 164.96M | 185.36M | 197.19M |
| Revenue Growth % | - | 0.06% | 0.2% | 0.18% | 0.12% | 0.06% |
| Cost of Goods Sold | 43.56M | 44.93M | 48.82M | 54.58M | 57.88M | 58.13M |
| COGS % of Revenue | 0.4% | 0.39% | 0.35% | 0.33% | 0.31% | 0.29% |
| Gross Profit | 66.41M | 71.64M | 90.58M | 110.38M | 127.48M | 139.06M |
| Gross Margin % | 0.6% | 0.61% | 0.65% | 0.67% | 0.69% | 0.71% |
| Gross Profit Growth % | - | 0.08% | 0.26% | 0.22% | 0.15% | 0.09% |
| Operating Expenses | 42.88M | 39.86M | 56.02M | 171.1M | 98.83M | 107.45M |
| OpEx % of Revenue | 0.39% | 0.34% | 0.4% | 1.04% | 0.53% | 0.54% |
| Selling, General & Admin | 39.29M | 37.43M | 53.96M | 171.1M | 0 | 107.45M |
| SG&A % of Revenue | 0.36% | 0.32% | 0.39% | 1.04% | - | 0.54% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - |
| Other Operating Expenses | 3.59M | 2.43M | 2.06M | 0 | 98.83M | 0 |
| Operating Income | 23.53M | 31.78M | 34.56M | -60.72M | 28.66M | 31.61M |
| Operating Margin % | 0.21% | 0.27% | 0.25% | -0.37% | 0.15% | 0.16% |
| Operating Income Growth % | - | 0.35% | 0.09% | -2.76% | 1.47% | 0.1% |
| EBITDA | 24.36M | 32.92M | 35.96M | -58.52M | 29.45M | 35.19M |
| EBITDA Margin % | 0.22% | 0.28% | 0.26% | -0.35% | 0.16% | 0.18% |
| EBITDA Growth % | - | 0.35% | 0.09% | -2.63% | 1.5% | 0.19% |
| D&A (Non-Cash Add-back) | 832K | 1.14M | 1.4M | 2.2M | 794K | 3.57M |
| EBIT | 23.46M | 31.78M | 34.58M | 5.76M | 38.74M | 12.02M |
| Net Interest Income | -2.08M | -2.42M | -1.67M | -4.05M | -6.36M | -11M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.08M | 2.42M | 1.67M | 4.05M | 6.36M | 11M |
| Other Income/Expense | -2.15M | -2.43M | -1.66M | 62.43M | -28.78M | -30.59M |
| Pretax Income | 21.38M | 29.35M | 32.91M | 1.71M | -123K | 1.02M |
| Pretax Margin % | 0.19% | 0.25% | 0.24% | 0.01% | -0% | 0.01% |
| Income Tax | 93K | 189K | 286K | 388K | 2.68M | 970K |
| Effective Tax Rate % | 1% | 0.99% | 0.99% | -0.57% | -26.96% | 3.11% |
| Net Income | 21.29M | 29.16M | 32.62M | -969K | 3.32M | 3.16M |
| Net Margin % | 0.19% | 0.25% | 0.23% | -0.01% | 0.02% | 0.02% |
| Net Income Growth % | - | 0.37% | 0.12% | -1.03% | 4.42% | -0.05% |
| Net Income (Continuing) | 21.29M | 29.16M | 32.62M | 1.32M | -2.81M | 46K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | -13.81M | -7.15M | 3.73M |
| EPS (Diluted) | 2.81 | 3.85 | -0.87 | 0.16 | 0.13 | 0.09 |
| EPS Growth % | - | 0.37% | -1.23% | 1.18% | -0.19% | -0.29% |
| EPS (Basic) | 2.81 | 3.85 | -0.87 | 0.16 | 0.13 | 0.09 |
| Diluted Shares Outstanding | 7.57M | 7.57M | 7.57M | 8.06M | 25.71M | 34.27M |
| Basic Shares Outstanding | 7.57M | 7.57M | 7.57M | 8.06M | 25.71M | 34.27M |
| Dividend Payout Ratio | - | - | 0.35% | - | 2.62% | 1.5% |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 19.3M | 27.82M | 47.09M | 101.18M | 122.34M | 68.13M |
| Cash & Short-Term Investments | 10.49M | 17.21M | 26.77M | 79.23M | 89M | 39.34M |
| Cash Only | 10.49M | 17.21M | 26.77M | 79.23M | 89M | 39.34M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 4.02M | 4.72M | 5.23M | 6.95M | 8.17M | 7.7M |
| Days Sales Outstanding | 13.33 | 14.78 | 13.7 | 15.37 | 16.1 | 14.26 |
| Inventory | 3.92M | 4.32M | 9.62M | 11.18M | 17.31M | 14.85M |
| Days Inventory Outstanding | 32.82 | 35.13 | 71.89 | 74.79 | 109.15 | 93.21 |
| Other Current Assets | 0 | 0 | 3.94M | 0 | 308K | 111K |
| Total Non-Current Assets | 4.59M | 4.76M | 7.25M | 10.47M | 32.95M | 54.24M |
| Property, Plant & Equipment | 2.76M | 2.17M | 2.69M | 3.56M | 3.1M | 10.22M |
| Fixed Asset Turnover | 39.79x | 53.84x | 51.80x | 46.39x | 59.89x | 19.30x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 5.83M |
| Intangible Assets | 1.82M | 2.6M | 4.55M | 5.07M | 4.97M | 9.38M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | -4.59M | 0 | 0 | 0 | 0 | 72K |
| Total Assets | 23.89M | 32.59M | 54.33M | 111.64M | 155.29M | 122.37M |
| Asset Turnover | 4.60x | 3.58x | 2.57x | 1.48x | 1.19x | 1.61x |
| Asset Growth % | - | 0.36% | 0.67% | 1.05% | 0.39% | -0.21% |
| Total Current Liabilities | 13.51M | 11.71M | 17.31M | 18.77M | 22.21M | 51.51M |
| Accounts Payable | 3.19M | 2.44M | 4.35M | 4.11M | 4.16M | 5.81M |
| Days Payables Outstanding | 26.72 | 19.86 | 32.52 | 27.5 | 26.2 | 36.5 |
| Short-Term Debt | 5M | 5M | 5M | 6.25M | 6.25M | 6.25M |
| Deferred Revenue (Current) | 0 | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 2.58M | 1.36M | 2.21M | 4.22M | 6.07M | 30.32M |
| Current Ratio | 1.43x | 2.38x | 2.72x | 5.39x | 5.51x | 1.32x |
| Quick Ratio | 1.14x | 2.01x | 2.16x | 4.80x | 4.73x | 1.03x |
| Cash Conversion Cycle | 19.43 | 30.04 | 53.07 | 62.66 | 99.04 | 70.97 |
| Total Non-Current Liabilities | 43.31M | 37.95M | 32.89M | 151.15M | 169.63M | 173.06M |
| Long-Term Debt | 41.52M | 36.74M | 31.96M | 112.09M | 106.63M | 101.2M |
| Capital Lease Obligations | 614K | 375K | 127K | 1.93M | 1.68M | 2.89M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.17M | 0 | 0 | 36.21M | 59.99M | 67.41M |
| Total Liabilities | 56.82M | 49.66M | 50.2M | 169.92M | 191.84M | 224.57M |
| Total Debt | 47.13M | 42.35M | 37.34M | 120.43M | 114.87M | 110.86M |
| Net Debt | 36.65M | 25.15M | 10.57M | 41.2M | 25.87M | 71.52M |
| Debt / Equity | - | - | 9.05x | - | - | - |
| Debt / EBITDA | 1.93x | 1.29x | 1.04x | - | 3.90x | 3.15x |
| Net Debt / EBITDA | 1.50x | 0.76x | 0.29x | - | 0.88x | 2.03x |
| Interest Coverage | 11.30x | 13.11x | 20.66x | -15.00x | 4.50x | 2.87x |
| Total Equity | -32.93M | -17.07M | 4.13M | -58.27M | -36.55M | -102.2M |
| Equity Growth % | - | 0.48% | 1.24% | -15.13% | 0.37% | -1.8% |
| Book Value per Share | -4.35 | -2.25 | 0.54 | -7.23 | -1.42 | -2.98 |
| Total Shareholders' Equity | -32.93M | -17.07M | 4.13M | -44.46M | -29.4M | -105.93M |
| Common Stock | 0 | 0 | 0 | 6K | 6K | 4K |
| Retained Earnings | -32.9M | -17.05M | 4.17M | -44.46M | -29.39M | -100.3M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | -5.6M |
| Accumulated OCI | -33K | -23K | -40K | -5K | -12K | -35K |
| Minority Interest | 0 | 0 | 0 | -13.81M | -7.15M | 3.73M |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 25.35M | 26.43M | 33.72M | -9.16M | 26.88M | 45.24M |
| Operating CF Margin % | 0.23% | 0.23% | 0.24% | -0.06% | 0.15% | 0.23% |
| Operating CF Growth % | - | 0.04% | 0.28% | -1.27% | 3.94% | 0.68% |
| Net Income | 21.29M | 29.16M | 32.62M | 1.32M | 3.32M | 46K |
| Depreciation & Amortization | 832K | 1.14M | 1.4M | 2.2M | 2.99M | 3.57M |
| Stock-Based Compensation | 0 | 0 | 0 | 82.18M | 9.06M | 8.73M |
| Deferred Taxes | 0 | 0 | 0 | -743K | 721K | -2.9M |
| Other Non-Cash Items | 837K | 1.71M | 1.16M | -58.3M | 19.72M | 25.85M |
| Working Capital Changes | 2.4M | -5.59M | -1.46M | -35.81M | -8.93M | 9.93M |
| Change in Receivables | -714K | -1.48M | -752K | -1.56M | -505K | -2.27M |
| Change in Inventory | 1.3M | -904K | -5.76M | -1.71M | -6.1M | 3.71M |
| Change in Payables | 1.22M | -884K | 1.6M | 416K | -165K | 1.54M |
| Cash from Investing | -1.67M | -1.39M | -3.81M | -1.84M | -2.71M | -18.8M |
| Capital Expenditures | -704K | -295K | -1.45M | -333K | -359K | -6.43M |
| CapEx % of Revenue | 0.01% | 0% | 0.01% | 0% | 0% | 0.03% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | -968K | -1.1M | -2.36M | -1.5M | -2.35M | -526K |
| Cash from Financing | -13.55M | -18.32M | -20.34M | 63.46M | -14.38M | -76.08M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | -56.63M | -13.32M | -11.4M | -12.89M | -8.69M | -4.74M |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | -1.11M | 0 | -3.94M | -8.05M | 420K | -59.77M |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | 23.68M | 25.03M | 29.91M | -10.99M | 24.17M | 38.81M |
| FCF Margin % | 0.22% | 0.21% | 0.21% | -0.07% | 0.13% | 0.2% |
| FCF Growth % | - | 0.06% | 0.19% | -1.37% | 3.2% | 0.61% |
| FCF per Share | 3.13 | 3.30 | 3.95 | -1.36 | 0.94 | 1.13 |
| FCF Conversion (FCF/Net Income) | 1.19x | 0.91x | 1.03x | 9.45x | 8.11x | 14.33x |
| Interest Paid | 1.63M | 2.49M | 1.46M | 4.43M | 9.48M | 9.54M |
| Taxes Paid | 178K | 189K | 171K | 282K | 4.43M | 2.59M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | 790.76% | - | - | - |
| Return on Invested Capital (ROIC) | 474.46% | 404.3% | 227.68% | - | - | - |
| Gross Margin | 60.39% | 61.46% | 64.98% | 66.92% | 68.78% | 70.52% |
| Net Margin | 19.36% | 25.02% | 23.4% | -0.59% | 1.79% | 1.6% |
| Debt / Equity | - | - | 9.05x | - | - | - |
| Interest Coverage | 11.30x | 13.11x | 20.66x | -15.00x | 4.50x | 2.87x |
| FCF Conversion | 1.19x | 0.91x | 1.03x | 9.45x | 8.11x | 14.33x |
| Revenue Growth | - | 5.99% | 19.58% | 18.34% | 12.37% | 6.38% |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Product Revenue | 163.13M | 182.57M | 192.24M |
| Product Revenue Growth | - | 11.92% | 5.29% |
| Dietary Supplements | 32.41M | 38.09M | 36.02M |
| Dietary Supplements Growth | - | 17.52% | -5.44% |
| Service Revenue | 1.82M | 2.79M | 4.95M |
| Service Revenue Growth | - | 52.80% | 77.65% |
| Other Service Revenue | - | 697K | 2.27M |
| Other Service Revenue Growth | - | - | 225.54% |
| Training Service Revenue | 973K | 1.17M | 1.46M |
| Training Service Revenue Growth | - | 20.25% | 24.44% |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| UNITED STATES | 164.52M | 181.84M | 196.2M |
| UNITED STATES Growth | - | 10.52% | 7.90% |
| All Other Country | 434K | 735K | 1.02M |
| All Other Country Growth | - | 69.35% | 38.64% |
biote Corp. (BTMD) has a price-to-earnings (P/E) ratio of 26.0x. This suggests investors expect higher future growth.
biote Corp. (BTMD) reported $195.6M in revenue for fiscal year 2024. This represents a 78% increase from $110.0M in 2019.
biote Corp. (BTMD) grew revenue by 6.4% over the past year. This is steady growth.
Yes, biote Corp. (BTMD) is profitable, generating $28.8M in net income for fiscal year 2024 (1.6% net margin).
Yes, biote Corp. (BTMD) pays a dividend with a yield of 5.79%. This makes it attractive for income-focused investors.
biote Corp. (BTMD) generated $34.8M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.